Related Articles
Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer
Role of neutrophil‑lymphocyte ratio, platelet‑lymphocyte ratio, lymphocyte‑monocyte ratio and platelets in prognosis of patients with prostate cancer
Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment
Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients
Platelet‑to‑lymphocyte and neutrophil‑to‑lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non‑small cell lung cancer